A-share listed mainland medical equipment manufacturer MINDRAY BIO-MEDICAL (300760.SZ) has selected Huatai Securities and JPMorgan to handle the preparation work for its IPO in Hong Kong, Bloomberg reported, quoting people with the knowledge of the matter.

More investment banks may be brought in later for this listing. Earlier market news had suggested that the company aims to raise at least USD1 billion through its Hong Kong listing.

Interim results showed that as of the end of June this year, the company's revenue for the first half was RMB16.743 billion, a YoY decrease of 18.4%, while net profit fell 33% to RMB5.069 billion.
(A Shares quote is delayed for at least 15 mins.)